Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,773 | -30,256 | -94,536 | -36,910 | -28,808 |
| Depreciation Amortization | 7,081 | 3,692 | 3,098 | 2,651 | 2,198 |
| Accounts receivable | 5,955 | -15,207 | 8,149 | -3,798 | -4,020 |
| Other Working Capital | -24,932 | 17,060 | 13,006 | 1,847 | 1,301 |
| Other Operating Activity | -42,319 | 61,839 | -9,582 | 14,354 | 10,684 |
| Operating Cash Flow | $-99,988 | $37,128 | $-79,865 | $-21,856 | $-18,645 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 101,327 | -147,804 | -40,721 | -12,832 | -73,234 |
| PPE Investments | -53,147 | -13,803 | -5,300 | -3,805 | -2,440 |
| Other Investing Activity | -29,711 | -25,039 | 500 | 0 | 0 |
| Investing Cash Flow | $18,469 | $-186,646 | $-45,521 | $-16,637 | $-75,674 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 94,570 | 31,524 | 4,561 | 3,483 | 1,741 |
| Debt Repayment | -64,877 | -17,078 | -2,313 | -1,666 | -984 |
| Common Stock Issued | 6,763 | 196,613 | 3,459 | 179,486 | 93,360 |
| Other Financing Activity | 236 | 0 | 104 | 0 | 15 |
| Financing Cash Flow | $36,692 | $211,059 | $5,811 | $181,303 | $94,132 |
| Beginning Cash Position | 105,854 | 44,313 | 163,888 | 21,078 | 21,265 |
| End Cash Position | 61,027 | 105,854 | 44,313 | 163,888 | 21,078 |
| Net Cash Flow | $-44,827 | $61,541 | $-119,575 | $142,810 | $-187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,988 | 37,128 | -79,865 | -21,856 | -18,645 |
| Capital Expenditure | -53,147 | -50,439 | -5,300 | -3,805 | -2,440 |
| Free Cash Flow | -153,135 | -13,311 | -85,165 | -25,661 | -21,085 |